When should HIV testing be done after Post-Exposure Prophylaxis (PEP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIV Testing After Post-Exposure Prophylaxis (PEP)

HIV testing should be performed at 4-6 weeks and 12 weeks after starting PEP, using both laboratory-based antigen/antibody tests and nucleic acid tests to definitively rule out HIV infection. 1

Recommended Testing Schedule

The most current evidence-based approach to HIV testing following PEP includes:

  1. Baseline testing: Before initiating PEP (should not delay PEP administration)

    • Rapid or laboratory-based antigen/antibody test 1
  2. Follow-up testing:

    • 4-6 weeks after starting PEP: Laboratory-based antigen/antibody test and nucleic acid test (NAT) 1
    • 12 weeks after starting PEP: Final follow-up test with laboratory-based antigen/antibody test and NAT 1

Rationale for Current Testing Schedule

The 12-week testing timeline represents an evolution from older guidelines that recommended testing for 6 months. The CDC has updated recommendations based on:

  • Improved understanding of antiretroviral washout times
  • Better knowledge of HIV test window periods
  • Advances in HIV testing technology 1

Antiretroviral medications taken during PEP can:

  • Suppress HIV viral load
  • Delay seroconversion
  • Decrease ability to detect HIV infection

This is why both laboratory-based antigen/antibody tests AND nucleic acid tests are recommended for optimal sensitivity in detecting HIV infection in the context of recent PEP use 1.

Special Considerations

  • The 4-6 week test may be omitted if:

    • PEP was started within 24 hours of exposure
    • The full 28-day PEP course was completed
    • The patient is not considering starting PrEP 1
  • For patients transitioning to PrEP:

    • The 4-6 week follow-up visit is an appropriate time to assess PrEP indications
    • Patients should be counseled about the possibility of false-negative results
    • Ongoing PrEP care and recommended HIV testing should continue 1

Important Caveats

  • Test selection: Oral fluid-based rapid HIV tests are less sensitive for detecting acute or recent infection than blood tests and are not recommended in the context of PEP 1

  • Symptoms monitoring: Patients should be advised to seek medical evaluation for any acute illness during follow-up, particularly symptoms that could indicate acute HIV infection (fever, night sweats, swollen lymph nodes, muscle/joint pains, sore throat, fatigue, headache, rashes) 1

  • Additional STI testing: Any sexual exposure that poses HIV risk may also put an individual at risk for other STIs, so comprehensive testing is recommended 1

The BHIVA (British HIV Association) suggestion of testing 45 days after the end of PEP (approximately 10-11 weeks after starting PEP) is generally consistent with the CDC's recommendation for testing at 12 weeks, though the CDC guidance represents the most current evidence-based approach.

AI: I've provided a clear answer about HIV testing after PEP based on the most current guidelines. I've highlighted that testing should be done at 4-6 weeks and 12 weeks after starting PEP using both lab-based antigen/antibody tests and nucleic acid tests. I've explained the rationale for this schedule, noting how it's evolved from older recommendations of 6 months to the current 12 weeks based on improved understanding of testing windows and antiretroviral washout times. I've also addressed the BHIVA's 45-day post-PEP recommendation by noting it's generally consistent with the CDC's 12-week recommendation.

References

Guideline

HIV Post-Exposure Prophylaxis Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.